| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A prime-boost immunization with Tc52 N-terminal domain DNA and the recombinant protein expressed in Pichia pastoris protects against Trypanosoma cruzi infection
|
Matos, Marina N.
|
|
2016
|
34 |
28 |
p. 3243-3251
9 p.
|
article
|
| 2 |
Calls by alternative medicine practitioners for vaccinated vs unvaccinated studies is not supported by evidence
|
Hawkes, David
|
|
2016
|
34 |
28 |
p. 3223-3224
2 p.
|
article
|
| 3 |
Characterization of the immune response induced by pertussis OMVs-based vaccine
|
Bottero, D.
|
|
2016
|
34 |
28 |
p. 3303-3309
7 p.
|
article
|
| 4 |
Communicating to increase public uptake of pandemic flu vaccination in the UK: Which messages work?
|
Mowbray, Fiona
|
|
2016
|
34 |
28 |
p. 3268-3274
7 p.
|
article
|
| 5 |
Detection and isolation of Bluetongue virus from commercial vaccine batches
|
Bumbarov, Velizar
|
|
2016
|
34 |
28 |
p. 3317-3323
7 p.
|
article
|
| 6 |
Development and validation of a quantitative competitive ELISA for potency testing of equine anti rabies sera with other potential use
|
Korimbocus, Jehanara
|
|
2016
|
34 |
28 |
p. 3310-3316
7 p.
|
article
|
| 7 |
Editorial Board/Aims and Scope
|
|
|
2016
|
34 |
28 |
p. IFC-
1 p.
|
article
|
| 8 |
Effective vaccine communication during the disneyland measles outbreak
|
Broniatowski, David A.
|
|
2016
|
34 |
28 |
p. 3225-3228
4 p.
|
article
|
| 9 |
Evaluation of various adjuvant nanoparticulate formulations for meningococcal capsular polysaccharide-based vaccine
|
Gala, Rikhav P.
|
|
2016
|
34 |
28 |
p. 3260-3267
8 p.
|
article
|
| 10 |
Hepatitis B vaccine stored outside the cold chain setting: a pilot study in rural Lao PDR
|
Kolwaite, Amy R.
|
|
2016
|
34 |
28 |
p. 3324-3330
7 p.
|
article
|
| 11 |
IgY against enterotoxigenic Escherichia coli administered by hydrogel-carbon nanotubes composites to prevent neonatal diarrhoea in experimentally challenged piglets
|
Alustiza, Fabrisio
|
|
2016
|
34 |
28 |
p. 3291-3297
7 p.
|
article
|
| 12 |
Impaired innate, humoral, and cellular immunity despite a take in smallpox vaccine recipients
|
Kennedy, Richard B.
|
|
2016
|
34 |
28 |
p. 3283-3290
8 p.
|
article
|
| 13 |
Influenza epidemiology among hospitalized children in Stockholm, Sweden 1998–2014
|
Bennet, Rutger
|
|
2016
|
34 |
28 |
p. 3298-3302
5 p.
|
article
|
| 14 |
Pneumococcal conjugate vaccine herd effects on non-invasive pneumococcal pneumonia in elderly
|
van Werkhoven, Cornelis H.
|
|
2016
|
34 |
28 |
p. 3275-3282
8 p.
|
article
|
| 15 |
Response to Orellano et al. regarding cost-utility analysis of dengue vaccination in a country with heterogeneous risk of dengue transmission
|
Urueña, Analía
|
|
2016
|
34 |
28 |
p. 3222-
1 p.
|
article
|
| 16 |
Route of administration of attenuated sporozoites is instrumental in rendering immunity against Plasmodia infection
|
Parmar, Rajesh
|
|
2016
|
34 |
28 |
p. 3229-3234
6 p.
|
article
|
| 17 |
Transmission blocking potency and immunogenicity of a plant-produced Pvs25-based subunit vaccine against Plasmodium vivax
|
Blagborough, A.M.
|
|
2016
|
34 |
28 |
p. 3252-3259
8 p.
|
article
|
| 18 |
Using behavior change frameworks to improve healthcare worker influenza vaccination rates: A systematic review
|
Corace, Kimberly M.
|
|
2016
|
34 |
28 |
p. 3235-3242
8 p.
|
article
|
| 19 |
Will dengue vaccination be cost-effective for Argentina? Reply to letter by Urueña et al. regarding “Cost-utility analysis of dengue vaccination in a country with heterogeneous risk of dengue transmission”
|
Orellano, Pablo Wenceslao
|
|
2016
|
34 |
28 |
p. 3221-
1 p.
|
article
|
Journal description